A carregar...
Rituximab-associated interstitial lung disease in fibrillary glomerulonephritis
Rituximab (RTX) is a chimeric monoclonal antibody against CD20+ B cells increasingly used to treat kidney disorders. RTX-induced pulmonary disease has been reported in patients treated for haematological disorders, and a few cases have been observed in patients with underlying rheumatological condit...
Na minha lista:
| Publicado no: | Clin Kidney J |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4438396/ https://ncbi.nlm.nih.gov/pubmed/26064515 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ckj/sft081 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|